What is AltaSci?
AltaSci Laboratories operates at the intersection of advanced analytical chemistry and regulatory compliance. The company specializes in comprehensive terpene analysis, utilizing state-of-the-art Gas Chromatography-Mass Spectrometry (GC-MS) to deliver high-fidelity data. A key differentiator for the firm is its commitment to rigorous quality standards, specifically through the United State Pharmacopeia (USP) validation of compendial procedures. This technical validation ensures that their analytical methods meet the stringent suitability requirements demanded by modern pharmaceutical and botanical industries, establishing AltaSci as a reliable partner for complex chemical profiling.
How much funding has AltaSci raised?
AltaSci has raised a total of $110K across 1 funding round:
Debt
$110K
Debt (2021): $110K with participation from PPP
Key Investors in AltaSci
PPP
Public-Private Partnership
What's next for AltaSci?
With the infusion of this late-stage capital, AltaSci is poised to transition into a phase of aggressive infrastructure scaling and service diversification. The strategic roadmap likely involves enhancing laboratory throughput to meet the rising demand for standardized terpene testing across global markets. Furthermore, the company is expected to leverage its validated USP methodologies to capture additional market share in adjacent sectors requiring high-precision analytical verification. As the regulatory landscape for botanical and chemical products continues to evolve, AltaSci's focus on validated, reproducible data will serve as a critical competitive moat, facilitating long-term growth and institutional adoption.
See full AltaSci company page
